Key result
Transcatheter therapies for tricuspid regurgitation are emerging as less invasive alternatives to medical and surgical treatments, with various techniques currently available or under study.
This review summarizes the rationale and current technologies for transcatheter treatment of tricuspid regurgitation.
Transcatheter TR therapies merit development amid limited options; leaves open efficacy, selection, and durability questions.
Nowadays, tricuspid regurgitation (TR) is a widespread condition and this has led to a not-unexpected interest in the "forgotten valve". Medical treatment and/or a surgical approach remain the gold standard for this valve disorder, although these approaches are often limited. In the era of transcatheter therapies, the primary interest for less invasive percutaneous approaches targeted to the treatment of TR can thus find a clear rationale for its evolution. The aim of this review is to explore the different transcatheter techniques for TR that are available or under study, and also to report on preliminary clinical results worldwide.
No takes yet. Share an insight, caveat, or question.
Grasso et al. (2018) conducted a review in Tricuspid regurgitation. Transcatheter treatment was evaluated. Transcatheter therapies for tricuspid regurgitation are emerging as less invasive alternatives to medical and surgical treatments, with various techniques currently available or under study.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: